  Opioid use disorder (OUD) continuously poses major public health challenges
and social implications worldwide with dramatic rise of opioid dependence
leading to potential abuse. Despite that a few pharmacological agents have been
approved for OUD treatment, the efficacy of said agents for OUD requires
further improvement in order to provide safer and more effective
pharmacological and psychosocial treatments. Preferable therapeutic treatments
of OUD rely on the advances in understanding the neurobiological mechanism of
opioid dependence. Proteins including mu, delta, kappa, nociceptin, and zeta
opioid receptors are the direct targets of opioids. Each receptor has a large
protein-protein interaction (PPI) network, that behaves differently when
subjected to various treatments, thus increasing the complexity in the drug
development process for an effective opioid addiction treatment. The report
below analyzes the work by presenting a PPI-network informed machine-learning
study of OUD. We have examined more than 500 proteins in the five opioid
receptor networks and subsequently collected 74 inhibitor datasets. Machine
learning models were constructed by pairing gradient boosting decision tree
(GBDT) algorithm with two advanced natural language processing (NLP)-based
molecular fingerprints. With these models, we systematically carried out
evaluations of screening and repurposing potential of drug candidates for four
opioid receptors. In addition, absorption, distribution, metabolism, excretion,
and toxicity (ADMET) properties were also considered in the screening of
potential drug candidates. Our study can be a valuable and promising tool of
pharmacological development for OUD treatments.
